Breadcrumb

In the Spotlight

New Milestones publication now available

Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 10 of our top scientific advances from the past year. These discoveries include advances in precision medicine — such as the identification of biomarkers that predict a patient’s response to immunotherapy or lead to health disparities — as well as research on a widely applicable cancer vaccine that could be employed in low-resource settings. Promising research on T cells provides insights into their resilience, behavior and tumor-reactivity with an eye toward developing better immunotherapies, and technological advances provide close-ups of key components of tumor growth and metastasis.

Read More

CCR postdoctoral researcher awarded Fulbright to study HPV and cervical cancer in Africa

Tsion Minas, Ph.D., is a recent recipient of a Fulbright U.S. Scholar Award. She joined the Laboratory of Human Carcinogenesis in 2016 to work with Senior Investigator Stefan Ambs, Ph.D., M.P.H., and study the molecular nature of cancers in African populations. In this Q&A, she shares her passion for closing disparity gaps in health research and how she plans to build upon her Fulbright work in the future.

Read More

Celebrating Asian American, Native Hawaiian, and Pacific Islander Heritage Month: A Conversation with Lilian Yang, M.B.A.

Lilian Yang, M.B.A., is the Senior Branch Manager in the Neuro-Oncology Branch (NOB). She is originally from Hawaii and identifies as Chinese American. In this Asian American, Native Hawaiian, and Pacific Islander Heritage Month Q&A, she talks to us about the many places she has lived, some valuable business school advice, and the need for Asian representation in leadership roles.

Read More

New Milestones publication now available

Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 14 of our top scientific advances from the past year. These discoveries include basic research to understand cancer cells, promising advances in immunotherapy for solid tumors, precision oncology for selecting the best treatment for a patient and new insights into the role of the tumor microenvironment and the microbiota in cancer treatment. Other major advances include new technology development achieved through interdisciplinary teamwork, health disparities research relating to prostate cancer and studies that led to several Food and Drug Administration approvals.

Read More